← FDA DRUG APPROVALS

FDA ANDA · ANDA062351

GENTAMICIN SULFATE

Sponsor: PADAGIS US

APPLICATION
ANDA062351
TYPE
ANDA
ORIGINAL APPROVAL
1982-02-18
LATEST ACTION
2009-12-04
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Prescription

Products

GENTAMICIN SULFATEPrescription
GENTAMICIN SULFATE EQ 0.1% BASE · OINTMENT · TOPICAL

Approval history

2009-12-04Labeling · Supplement 20AP
2009-04-17Labeling · Supplement 19AP
2003-05-21Labeling · Supplement 17AP
2002-11-26Manufacturing (CMC) · Supplement 16AP
2002-03-14Manufacturing (CMC) · Supplement 15AP
1993-05-21Labeling · Supplement 14AP
1987-07-13Manufacturing (CMC) · Supplement 13AP
1982-02-18OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →